Pyxis Oncology Inc
(PYXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 20,954 | 37,973 | 28,393 | 25,726 | 31,389 |
| Operating Income | -20,954 | -37,973 | -28,393 | -25,726 | -31,389 |
| Other Income | 1,711 | 1,872 | 719 | 164 | 9 |
| Pre-tax Income | -19,243 | -36,101 | -27,674 | -25,562 | -31,380 |
| Net Income Continuous | -19,243 | -36,101 | -27,674 | -25,562 | -31,380 |
| Net Income | $-19,243 | $-36,101 | $-27,674 | $-25,562 | $-31,380 |
| EPS Basic Total Ops | -0.54 | -1.04 | -0.85 | -0.79 | -0.97 |
| EPS Basic Continuous Ops | -0.54 | -1.05 | -0.85 | -0.79 | -0.97 |
| EPS Diluted Total Ops | -0.54 | -1.04 | -0.85 | -0.79 | -0.97 |
| EPS Diluted Continuous Ops | -0.54 | -1.05 | -0.85 | -0.79 | -0.97 |
| EBITDA(a) | $-21,371 | $-37,781 | $-28,193 | $-25,567 | $-31,231 |